We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$347M
AUM Growth
+$3.28M
Cap. Flow
+$7.65M
Cap. Flow %
2.2%
Top 10 Hldgs %
56.15%
Holding
100
New
3
Increased
56
Reduced
11
Closed
7

Top Buys

Rank Stock Value
1
ADPT icon
Adaptive Biotechnologies
ADPT
+$2.06M
2
FIS icon
Fidelity National Information Services
FIS
+$1.81M
3
NVDA icon
NVIDIA
NVDA
+$981K
4
ZION icon
Zions Bancorporation
ZION
+$851K
5
MSFT icon
Microsoft
MSFT
+$581K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.09M
2
ALGN icon
Align Technology
ALGN
+$1.82M
3
UNP icon
Union Pacific
UNP
+$1.01M
4
MRK icon
Merck
MRK
+$1.01M
5
SWK icon
Stanley Black & Decker
SWK
+$726K

Sector Composition

Rank Sector Weight
1 Healthcare 34.66%
2 Industrials 16.98%
3 Technology 14.23%
4 Energy 10.57%
5 Financials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GH icon
26
Guardant Health
GH
$19.5B
$2.75M 0.79%
43,017
+1,011
+2% +$89.1K
HD icon
27
Home Depot
HD
$332B
$2.5M 0.72%
10,751
+1,063
+11% +$232K
ABT icon
28
Abbott
ABT
$180B
$2.43M 0.7%
29,016
+2,662
+10% +$226K
EOG icon
29
EOG Resources
EOG
$78B
$2.33M 0.67%
31,369
+1,263
+4% +$102K
BAC icon
30
Bank of America
BAC
$435B
$2.32M 0.67%
79,415
+3,071
+4% +$88.3K
ICE icon
31
Intercontinental Exchange
ICE
$82.4B
$2.19M 0.63%
23,703
+2,610
+12% +$238K
IFF icon
32
International Flavors & Fragrances
IFF
$19.4B
$2.02M 0.58%
16,466
– –
SAGE
33
DELISTED
Sage Therapeutics
SAGE
$1.97M 0.57%
14,010
+107
+0.8% +$17.9K
TFX icon
34
Teleflex
TFX
$5.85B
$1.92M 0.55%
5,644
+690
+14% +$241K
TEL icon
35
TE Connectivity
TEL
$58.8B
$1.86M 0.54%
20,000
– –
NSC icon
36
Norfolk Southern
NSC
$78.8B
$1.84M 0.53%
10,251
+988
+11% +$182K
BDX icon
37
Becton Dickinson
BDX
$43.1B
$1.83M 0.53%
7,406
+736
+11% +$182K
COST icon
38
Costco
COST
$415B
$1.81M 0.52%
6,277
+580
+10% +$163K
ILMN icon
39
Illumina
ILMN
$29.4B
$1.72M 0.5%
5,812
+27
+0.5% +$7.96K
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.69M 0.49%
25,000
– –
ZION icon
41
Zions Bancorporation
ZION
$10.1B
$1.68M 0.48%
37,180
+19,686
+113% +$851K
CI icon
42
Cigna
CI
$76.6B
$1.61M 0.46%
10,618
+1,193
+13% +$194K
HON icon
43
Honeywell
HON
$77.1B
$1.6M 0.46%
10,019
+928
+10% +$148K
NEE icon
44
NextEra Energy
NEE
$187B
$1.6M 0.46%
27,416
+2,988
+12% +$162K
AVGO icon
45
Broadcom
AVGO
$1.82T
$1.59M 0.46%
57,700
+10,270
+22% +$292K
ADPT icon
46
Adaptive Biotechnologies
ADPT
$3.56B
$1.56M 0.45%
+50,459
New +$2.06M
CB icon
47
Chubb
CB
$140B
$1.55M 0.45%
9,591
+1,048
+12% +$162K
CSCO icon
48
Cisco
CSCO
$450B
$1.5M 0.43%
30,387
+3,099
+11% +$161K
DIS icon
49
Walt Disney
DIS
$165B
$1.49M 0.43%
11,427
+408
+4% +$56.4K
CRM icon
50
Salesforce
CRM
$134B
$1.49M 0.43%
10,019
+1,183
+13% +$180K
1
2
3 4

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Aristotle Atlantic Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Aristotle Atlantic Partners held 100 positions worth $347M, up 0.95% from $344M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Aristotle Atlantic Partners's Q3 2019 filing shows 3 new, 56 increased, 11 reduced and 7 closed positions. Its largest new stake was Adaptive Biotechnologies: 50,459 shares worth $1.56M. The largest sale was Allergan plc, an estimated $2.09M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 36% a quarter earlier, followed by Industrials and Technology.

  • Aristotle Atlantic Partners's largest Q3 2019 buy was Adaptive Biotechnologies: 50,459 shares worth $1.56M.
  • Aristotle Atlantic Partners added most to Fidelity National Information Services in Q3 2019, an estimated $1.81M increase.
  • Aristotle Atlantic Partners's biggest Q3 2019 reduction was Union Pacific, cutting an estimated $1.01M.
  • Aristotle Atlantic Partners fully exited Allergan plc in Q3 2019, selling an estimated $2.09M.
  • Aristotle Atlantic Partners's ten largest holdings make up 56% of its $347M portfolio in Q3 2019.
  • Aristotle Atlantic Partners opened 3 new positions and closed 7 in Q3 2019.
  • Aristotle Atlantic Partners's portfolio value rose 0.95% quarter-over-quarter to $347M.

Based on Aristotle Atlantic Partners's 13F filing for Q3 2019, filed 14 Nov 2019.